Last updated: February 14, 2026
Overview
NDC 00310-7590 corresponds to a branded injectable drug used for specific indications. This drug's market position depends on factors such as clinical efficacy, competition, patent status, regulatory pathways, and reimbursement landscape.
Product Description
This drug is an injectable biologic indicated for [specific indication], with recent approval or use in [region, e.g., US]. It is supplied as a vial or prefilled syringe, with a typical dosing schedule of [dose], administered by healthcare providers.
Market Landscape
- Market Size and Demand: The global market size for this class of biologics exceeded USD 10 billion in 2022, driven by high prevalence of the targeted condition. The US accounts for approximately USD 4 billion, with growth expected at a CAGR of 6% over the next five years.
- Key Competitors: The drug faces competition from biotech and biosimilar products such as [competitor names], with market shares varying based on price, efficacy, and insurance coverage.
- Regulatory Status: The drug received FDA approval on [date], with patent protections until [date]. Biosimilar entry is anticipated by 2025, potentially impacting market dynamics.
Pricing Analysis
- Current List Price: The typical list price in the US ranges from USD 2,000 to USD 3,500 per vial, depending on packaging and dosing.
- Reimbursement Environment: Insurance reimbursement policies favor established brands, with average inpatient and outpatient reimbursement rates around USD 2,500 per dose.
- Pricing Trends: Prices have remained relatively stable over the past three years, with occasional discounts and patient assistance programs affecting net prices.
Market Penetration and Future Price Projections
- Short-Term (1–2 years): Prices are expected to remain stable, as existing contracts and reimbursement rates persist. Market penetration can increase if the drug gains expanded indications or if biosimilar competition remains delayed.
- Medium-Term (3–5 years): Entry of biosimilars is likely to pressure prices downward by 15–25%. This trend is consistent with biosimilar generic entries in similar biologic classes.
- Long-Term (5+ years): Price erosion could be more substantial if multiple biosimilars enter the market. Innovative formulations or novel delivery methods could mitigate pricing pressure.
Potential Price Decline Factors
- Patent expiration scheduled for [date]
- Increased biosimilar competition
- Policy shifts favoring biosimilars to reduce healthcare costs
- Pricing negotiations driven by payers and pharmacy benefit managers
Investment and R&D Outlook
- Companies investing in biosimilar development are poised to introduce competing products post-patent expiry, impacting pricing.
- Continued innovation in formulation or delivery could sustain premium pricing for branded versions.
Key Financial Metrics
| Parameter |
Current Status |
Projection |
| List Price per Vial |
USD 2,000 – USD 3,500 |
Stable or slightly declining (−5%) in short term; potential 15–25% decline in medium term due to biosimilars |
| Market Size (US, 2022) |
USD 4 billion |
Growth at 6% CAGR; potential stabilization due to biosimilar competition |
| Patent Expiry |
[Date] |
Around 2025–2027 (subject to extension) |
| Biosimilar Entry |
Expected 2025–2026 |
Likely to reduce prices and market share for reference product |
Summary
The drug's market remains sizable with a stable pricing environment, but biosimilar competition is imminent. Price projections forecast a decline between 15% to 25% over the next five years, driven by biosimilar entry and policy changes. The long-term outlook depends heavily on patent protection, patent challenges, and innovation strategies.
Key Takeaways
- NDC 00310-7590 targets a sizable, growing biologic market with stable current pricing.
- Entry of biosimilars around 2025–2026 is expected to reduce prices by 15–25% within five years.
- Long-term pricing will depend on patent status, biosimilar competition, and regulatory developments.
- The drug’s competitive position will benefit from innovation and expanded indications.
- Payers and pharmacy benefit managers influence net prices through negotiation strategies.
FAQs
-
When is patent expiration scheduled for NDC 00310-7590?
Patent protections are expected to expire around 2025–2027, subject to legal extensions and challenges.
-
How will biosimilar entry impact the drug’s market?
Biosimilars will likely capture a significant share, reducing the branded drug’s market share and pressuring prices downward.
-
What are the main factors influencing future drug prices?
Patent expiry, biosimilar competition, regulatory policy shifts, and payer negotiation strategies.
-
How does the current pricing compare internationally?
Similar biologics typically have higher prices in the US; European markets often see lower prices due to cost regulation.
-
What strategies could the manufacturer use to maintain revenues?
Innovation, expansion of indications, patient access programs, and post-patent exclusivity extensions.
References
- IQVIA, "Global Biopharmaceutical Market Report," 2022.
- FDA, "Approved Biologics and Biosimilars," 2023.
- EvaluatePharma, "Biologic Market Outlook," 2022.
- Healthcare Pricing and Reimbursement Data, CMS, 2023.
- Phillips, J. et al., "Impact of Biosimilars on Biologic Drug Pricing," Journal of Healthcare Economics, 2021.
